Clinical Trials in Anchorage, United States
Locations / Anchorage, United States
Delta Trials hosts 96 clinical trials conducted in Anchorage, United States, making it a notable site of clinical research activity. These trials covering 691 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for Anchorage.
96
Total Trials
691
Conditions
0
Terminated since 2020
Browse by condition (691 total)
- Recurrent malignant solid neoplasm 6 trialsAll Recurrent malignant solid neoplasm trials
- Malignant solid neoplasm 5 trialsAll Malignant solid neoplasm trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Advanced malignant solid neoplasm 4 trialsAll Advanced malignant solid neoplasm trials
- Refractory malignant solid neoplasm 4 trialsAll Refractory malignant solid neoplasm trials
- Metastatic malignant solid neoplasm 4 trialsAll Metastatic malignant solid neoplasm trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Lung non-small cell carcinoma 3 trialsAll Lung non-small cell carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Recurrent hepatoblastoma 3 trialsAll Recurrent hepatoblastoma trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Refractory soft tissue sarcoma 3 trialsAll Refractory soft tissue sarcoma trials
- Ovarian seromucinous carcinoma 3 trialsAll Ovarian seromucinous carcinoma trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- Wilms tumor 3 trialsAll Wilms tumor trials
- All Endometrial mixed cell adenocarcinoma trials
- Recurrent endometrial carcinoma 3 trialsAll Recurrent endometrial carcinoma trials
- Recurrent osteosarcoma 3 trialsAll Recurrent osteosarcoma trials
- Stage ii lung cancer ajcc v8 3 trialsAll Stage ii lung cancer ajcc v8 trials